Photocatalytic Generation of Hydrogen Radical (H⋅) with GSH for Photodynamic Therapy

Angew Chem Int Ed Engl. 2023 Feb 20;62(9):e202214991. doi: 10.1002/anie.202214991. Epub 2023 Jan 24.

Abstract

As a reactive hydrogen species, the hydrogen radical (H⋅) scarcely sees applications in tumor biological therapy due to the very limited bio-friendly sources of H⋅. In this work, we report that TAF can act as an organic photosensitizer as well as an efficient photocatalytic H⋅ generator with reduced glutathione (GSH) as a fuel. The photoactivation of TAF leads to cell death in two ways including triple amplification of oxidative stress via ferroptosis-apoptosis under normoxia and apoptosis through biological reductions under hypoxia. TAF presents excellent biosafety with ultrahigh photocytotoxicity index at an order of magnitude of 102 -103 on both normoxic and hypoxic cells. The in vitro data suggest that H⋅ therapy is promising to overcome the challenge of tumor hypoxia at low doses of both photocatalyst and light. In addition, the capability of near-infrared two-photon excitation would benefit broad biological applications.

Keywords: Activatable Photodynamic Therapy; Glutathione Depletion; Photoredox Catalysis; Tumor Hypoxia; Two-Photon Excitation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Cell Death
  • Cell Line, Tumor
  • Glutathione / metabolism
  • Humans
  • Hypoxia / drug therapy
  • Neoplasms* / drug therapy
  • Photochemotherapy*
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use
  • Reactive Oxygen Species / metabolism

Substances

  • Reactive Oxygen Species
  • Photosensitizing Agents
  • Glutathione